1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Hormonal Contraceptive Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

Hormonal Contraceptive Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • February 2018
  • 230 pages
  • ID: 5371934

Summary

Table of Contents

Hormonal Contraceptive Market by Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, and Transdermal Patches), Hormone (Progestin-only Contraceptive and Combined Hormonal Contraceptive), Age Group (15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years), and End User (Hospitals, Household, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global hormonal contraceptive market was valued at $13,924 million in 2016, and is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023. Hormonal contraception is a birth control method, which acts on the endocrine system, and is composed of steroid hormones. Higher concentration of naturally forming hormones such as estrogen and progesterone are used to either prevent ovulation or make unfavorable condition to develop pregnancy.

Increase in adoption of hormonal contraceptives products or birth control methods in the developing countries and incidence of polycystic ovary syndrome (PCOS) are the major driving factors for the growth of the global hormonal contraceptive market. Moreover, rise in population attaining higher education and rise in need to control the ever-growing population in developing regions such as China and India have adopted measures to prevent unwanted pregnancy, which are expected to fuel the market growth. However, availability of alternate contraceptive methods and health risks associated with the use of contraceptives hamper the market growth.

The global hormonal contraceptive market is segmented on the basis of product, hormone, age group, end user, and geography. Based on product, the market is classified into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches. Depending on hormone, it is bifurcated into progestin-only contraceptive and combined hormonal contraceptive. By age group, it is categorized into 15–24 years, 25–34 years, 35–44 years, and above 44 years. By end user, it is classified into hospitals, household, and clinics. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS
This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Product
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Rings
Transdermal Patches

By Hormone
Progestin-only Contraceptive
Combined Hormonal Contraceptive

By Age Group
15–24 Years
25–34 Years
35–44 Years
Above 44 Years

By End User
Hospitals
Household
Clinics

By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY PLAYERS PROFILED
The Female Health Company
Teva Pharmaceutical Industries Limited
Bayer AG
Pfizer, Inc.
Mylan N.V.
Johnson & Johnson
Ansell Ltd.
Mayer Laboratories
Merck & Co., Inc.
Church & Dwight, Co., Inc.

The other players of the hormonal contraceptive market include (companies not profiled in the report):
Reckitt Benckiser Plc.
Warner Chilcott Company
BioSante Pharmaceuticals Inc.
HLL Lifecare Limited
Boehringer Ingelheim GmbH
Watson Pharmaceuticals, Inc.
V-Care Pharma Pvt. Ltd.
Vardhman Life Care Pvt. Ltd.
Cipla Limited

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Emergency Contraceptive Pill Market 2018-2022

Emergency Contraceptive Pill Sector: Worldwide Forecast until 2022

  • $ 2500
  • Industry report
  • July 2018
  • by Infiniti Research Limited

About Emergency Contraceptive PillAn emergency contraceptive pill is a short-term method of contraception that needs to be consumed within 72 hours of unprotected sexual intercourse, sexual assault, lapse ...

Female Contraception R&D Pipeline Analysis Report, H2-2018

Female Contraception R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • Industry report
  • August 2018
  • by VPAResearch

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studiesFemale Contraception Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information ...

Global Contraceptive Market: Industry Analysis & Outlook (2018-2022)

Global Contraceptive Market: Industry Analysis & Outlook (2018-2022)

  • $ 800
  • Industry report
  • October 2018
  • by Koncept Analytics

Contraception, also referred to as birth control, is a method to control unwanted pregnancy.It has been used since ancient times; however, effective contraceptive methods have been introduced in 20th century ...


Download Unlimited Documents from Trusted Public Sources

Contraceptive Demographic Impact in East Africa

  • October 2018
    4 pages
  • Contraceptive  

  • Africa  

    Kenya  

    Uganda  

View report >

Contraceptive Industry in the US

  • September 2018
    50 pages
  • Contraceptive  

    Hormone  

    Dementia  

  • United States  

View report >

Pain Relief Industry in Italy

  • September 2018
    147 pages
  • Pain Relief  

    Hospital  

    Therapy  

  • Italy  

View report >

Condom Supply 1 month ago

Condom Supply 1 month ago

OTC Markets in India 2 months ago


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on